Full description
Dataset includes: demographic data, diagnostic data, and safety data for a pilot study of 6 participants with early stage non small cell lung cancer (NSCLC) to evaluate the safety of a personalised tumour neo-antigen peptide vaccine strategy. The personalised neo-antigen peptide vaccine will comprise of 5 to 10 candidate tumour neo-antigens identified by genome sequencing.Notes
HeSANDA 1.0.0Submitted: 2019-05-17
Updated: 2021-05-03
Spatial Coverage And Location
text: Australia
Subjects
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Identifiers
- DOI : 10.60854/DSYQ-QG20
- global : dabdd15c-b5e0-4a9b-9dee-4bdd641496d4